CAPSTONE ASSET MANAGEMENT CO - SCICLONE PHARMACEUTICALS INC ownership

SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 138 filers reported holding SCICLONE PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
CAPSTONE ASSET MANAGEMENT CO ownership history of SCICLONE PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2017$303,000
+9.0%
27,590
-2.6%
0.01%0.0%
Q1 2017$278,000
-14.5%
28,340
-5.8%
0.01%
-11.1%
Q4 2016$325,000
+112.4%
30,090
+101.1%
0.01%
+125.0%
Q3 2016$153,000
-22.3%
14,960
-0.7%
0.00%
-33.3%
Q2 2016$197,00015,0700.01%
Other shareholders
SCICLONE PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Athos Capital Ltd 410,389$4,596,0003.46%
GLG Partners LP 2,586,437$28,968,0001.54%
Nine Chapters Capital Management LLC 32,300$362,0000.80%
FNY Partners Fund LP 335,900$3,762,0000.64%
MENTA CAPITAL LLC 373,523$4,183,0000.61%
Yakira Capital Management, Inc. 85,500$958,0000.32%
Sapphire Star Partners LP 18,724$209,0000.27%
GAM Holding AG 541,025$6,059,0000.26%
Bowling Portfolio Management LLC 127,873$1,432,0000.22%
Kassirer Asset Management Corp 15,000$168,0000.16%
View complete list of SCICLONE PHARMACEUTICALS INC shareholders